THE CURRENT STATUS OF IMMUNOMODULATORY APPROACHES IN THE TREATMENT OF CHRONIC HEPATITIS B

Authors

  • Mukhiddin Numonjonov Andijan state medical institute, assistant, department of Biochemistry, PhD researcher, Kokand State University Author
  •  Nematov Khondamir Andijan state medical institute. 2-year students Faculty of General Medicine Author
  • Zokirov Mironshokh Andijan state medical institute. 2-year students Faculty of General Medicine Author
  • Eraliyeva Madina Andijan state medical institute. 2-year students Faculty of General Medicine Author
  • Ahmadaliyeva Nasiba Andijan state medical institute. 2-year students Faculty of General Medicine Author
  •  Khoshimova Dildora Andijan state medical institute. 2-year students Faculty of General Medicine Author

Keywords:

chronic hepatitis B, immunomodulation, immunopathogenesis, interferon-alpha, HBV-specific T cells, therapeutic vaccines, hepatitis B surface antigen (HBsAg), immunotherapy.

Abstract

 Chronic hepatitis B is a major global health concern caused by the hepatitis B virus (HBV) and is associated with persistent liver inflammation, progressive fibrosis, liver cirrhosis, and an increased risk of hepatocellular carcinoma. The development and persistence of chronic HBV infection are determined not only by the biological characteristics of the virus but also by the complex interactions between the virus and the host's innate and adaptive immune responses. Therefore, in addition to suppressing viral replication, the modulation of antiviral immune responses has become an important area of research in the management of chronic hepatitis B. This article reviews the immunopathogenesis of chronic hepatitis B, the role of interferon-alpha-based therapy, and emerging immunotherapeutic strategies investigated in combination with nucleos(t)ide analogues. Particular attention is given to therapeutic vaccines, immune checkpoint inhibitors, and approaches aimed at restoring HBV-specific T-cell responses.

References

1.World Health Organization. Guidelines for the prevention, diagnosis, care and treatment for people with chronic hepatitis B infection. Geneva: World Health Organization; 2024. ISBN: 978-92-4-009090-3.

2.European Association for the Study of the Liver. EASL Clinical Practice Guidelines on the management of hepatitis B virus infection. Journal of Hepatology. 2025.

3.Terrault NA, Lok ASF, McMahon BJ, et al. Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance. Hepatology. 2018;67(4):1560–1599. doi:10.1002/hep.29800.

4.Maini MK, Burton AR. Restoring, releasing or replacing adaptive immunity in chronic hepatitis B. Nature Reviews Gastroenterology & Hepatology. 2019;16:662–675.

5.Bertoletti A, Ferrari C. Adaptive immunity in HBV infection. Journal of Hepatology. 2016;64(1 Suppl)–S83. doi:10.1016/j.jhep.2016.01.026.

6.Numonjonov, M. G., Parpiyev, A. T., Numonjonova, M. G., & Bozorboyev, S. A. (2021). Vitamines in the yarrow (achillea millefoliuml.) plant and their importance in human health. ACADEMICIA: An International Multidisciplinary Research Journal, 11(6), 912-917.

7.Numonjonov, M. G., Parpiyev, A. T., Bozorboyev Sh, A., & Vakhobova Sh, A. (2020). Alkaloids in some medicinal plants (Capparis L, Hypericum L, Achillea L,) their structure and significance. Science and education scientific journal ISSN, 2181-0842.

8.Tojiboyev, M. U., & Tuychiyeva, D. S. (2019). Qovoq o’simligining kimyoviy tarkibi va shifobaxsh xususiyatlari. Молодой ученый, (43), 298-301.

9.Mamatova, I. U., Khakimova, R., & Askarov, I. R. (2020). Evaluation of the effectiveness of food additives of “Astosh” and “Majmui Rakhmoniy”. Scientific Bullitein of the Namangan State University, 11, 93-97.

10.No'monjonov, M. G., No'monjonova, M. G., & Tojiboyev-T, M. U. (2021). Ayrim dorivor o'simliklarning morfo-biologik tasnifi, kimyoviy tarkibi va yetishtirish texnologiyasi. Образование и наука в XXI веке, 2(15), 946-949.

11.No‘monjonov, M. (2022). POLISAXARIDLARNING KIMYOVIY VA BIOLOGIK XOSSALARI VA ULARNING INSON SALOMATLIGIDA TUTGAN O ‘RNI. INTERNATIONAL СONFERENCES, 1(1), 4-9.

12.Numonjonov, M. (2021). Effects of certain alkaloids found in the Capparis L. Plant on human health. Интернаука, (25-2), 59-61.

13.Revill PA, Chisari FV, Block JM, et al. A global scientific strategy to cure hepatitis B. The Lancet Gastroenterology & Hepatology. 2019;4(7):545–558. doi:10.1016/S2468-1253(19)30119-0.

Guidotti LG, Chisari FV. Immunobiology and pathogenesis of viral hepatitis. Annual Review of Pathology. 2006;1:23–61. doi:10.1146/annurev.pathol.1.110304.10

Downloads

Published

2026-11-18